Xylophilous Fungal Infection (Wood‑Rot Fungus): A Patient‑Focused Guide

Overview

Xylophilous fungal infection, commonly referred to as “wood‑rot fungus” infection, is a rare but clinically important condition caused by fungi that normally thrive on decaying wood. While most of these organisms live harmlessly in the environment, they can become opportunistic pathogens when they gain access to human tissue—most often through a wound that contacts contaminated wood, soil, or dust.

Typical agents include Chaetomium spp., Aspergillus spp. (particularly A. fumigatus and A. niger when wood is the source), and less frequently Trichoderma spp. In immunocompetent individuals the infection usually remains localized to the skin or subcutaneous tissue, but in people with weakened immune systems it can spread, leading to deep‑tissue or even systemic disease.

• Who it affects: Outdoor workers (lumberjacks, carpenters, landscapers), agricultural laborers, hikers, and anyone with frequent exposure to moist, decaying wood. Immunocompromised patients (e.g., organ‑transplant recipients, people on long‑term steroids) are at higher risk for invasive disease.
• Prevalence: Exact incidence is not well defined because cases are sporadic and often under‑reported. In the United States, the CDC records fewer than 100 confirmed cases per year of “subcutaneous mycoses” caused by wood‑associated fungi, but prevalence is higher in tropical and subtropical regions where wood decay is common.

Symptoms

Symptoms depend on the depth of fungal infiltration and the host’s immune status. The most common presentation is a localized skin lesion at the site of inoculation.

Cutaneous / Subcutaneous Infection

• Redness (erythema): Often the first sign, ranging from mild pinkness to deep crimson.
• Swelling (edema): May be tender to touch.
• Pain or pruritus: Varies from a dull ache to sharp stabbing pain.
• Ulceration or drainage: Small pits, fissures, or purulent discharge develop after 1–3 weeks.
• Granulomatous nodule: Firm, raised bump that may become pigmented.
• “Wood‑like” consistency: In chronic cases the lesion feels hard, mimicking a piece of wood embedded in the tissue.

Deep Tissue / Musculoskeletal Involvement

• Progressive swelling extending beyond the skin.
• Limited range of motion if joints or tendons are involved.
• Fever, chills, and malaise (more common in immunocompromised hosts).
• Sinus tract formation that can drain foul‑smelling material.

Systemic Dissemination (Rare)

• Persistent high‑grade fever.
• Respiratory symptoms (cough, shortness of breath) if the fungus spreads to the lungs.
• Neurologic signs (headache, confusion) if cerebral involvement occurs.

Causes and Risk Factors

Primary Causes

• Inoculation through trauma: A cut, puncture, or abrasion that contacts contaminated wood provides a portal of entry.
• Environmental exposure: Working in damp, decaying‑wood environments (sawmills, construction sites, forests).
• Inhalation of spores: Rarely, airborne conidia can settle on broken skin or be aspirated, leading to pulmonary involvement that later seeds the skin.

Risk Factors

• Occupational exposure to wood (lumber, carpentry, forestry).
• Chronic skin conditions (eczema, psoriasis) that compromise barrier function.
• Immunosuppression (organ transplant, HIV/AIDS, chemotherapy, high‑dose corticosteroids).
• Diabetes mellitus with peripheral vascular disease.
• Living in humid climates or areas with high rainfall.
• Previous history of fungal infections.

Diagnosis

Accurate diagnosis combines a thorough history, physical examination, and targeted laboratory studies.

Clinical Evaluation

• Detailed occupational and exposure history.
• Inspection of the lesion for characteristic granulomatous or woody texture.
• Assessment of immune status (CBC, HIV test if indicated).

Laboratory & Imaging Tests

• Skin or tissue biopsy: Gold standard. Histopathology shows hyphal elements (septate, branching) and may reveal granulomatous inflammation.
• Fungal culture: Specimens are placed on Sabouraud dextrose agar; growth patterns help identify the species.
• Polymerase chain reaction (PCR) / DNA sequencing: Rapid species identification, especially useful for rare fungi.
• Serology: Limited utility; some labs can detect antibodies against specific molds.
• Imaging: Ultrasound or MRI for deep tissue involvement; CT scans if pulmonary spread is suspected.

Diagnostic Criteria (Simplified)

1. History of wood exposure and skin break.
2. Characteristic lesion on physical exam.
3. Microscopic evidence of filamentous fungi in tissue.
4. Positive culture or molecular identification of a wood‑associated fungus.

Treatment Options

Treatment aims to eradicate the fungus, preserve function, and prevent spread. Management is individualized based on depth of infection, species, and patient factors.

Antifungal Medications

• Oral itraconazole: 200 mg twice daily for 6–12 weeks; effective for many Aspergillus and Chaetomium infections. Monitor liver enzymes.
• Oral voriconazole: 200 mg twice daily; preferred for invasive disease or when itraconazole intolerance occurs. Requires therapeutic drug monitoring.
• Terbinafine: 250 mg daily; useful for dermatophyte‑like wood fungi.
• Amphotericin B (liposomal): Reserved for severe, disseminated cases; administered intravenously.

Procedural Interventions

• Surgical excision: Complete removal of localized granulomas or necrotic tissue reduces fungal load and speeds healing.
• Debridement & drainage: Necessary for abscess formation or sinus tracts.
• Hyperbaric oxygen therapy (HBOT): Adjunctive in refractory cases; improves tissue oxygenation and enhances antifungal efficacy.

Supportive & Lifestyle Measures

• Wound care with sterile dressings.
• Optimizing glycemic control in diabetic patients.
• Temporarily reducing immunosuppressive drugs when safe (under physician supervision).
• Ensuring adequate nutrition and protein intake for tissue repair.

Living with Xylophilous Fungal Infection (Wood‑Rot Fungus)

Even after successful treatment, ongoing self‑care helps prevent recurrence and promotes recovery.

Daily Management Tips

1. Wound hygiene: Clean the site daily with mild soap and water; apply prescribed topical antifungal or antiseptic ointments.
2. Inspect for changes: Look for new redness, swelling, or drainage and record any symptoms.
3. Medication adherence: Complete the full antifungal course even if you feel better.
4. Protective clothing: Wear gloves, long sleeves, and waterproof boots when handling wood or gardening.
5. Monitor blood work: Follow up labs (liver function, complete blood count) as ordered.
6. Physical therapy: If joints or tendons were involved, guided exercises maintain range of motion.
7. Psychological support: Chronic skin lesions can affect self‑esteem; consider counseling or support groups.

Prevention

Because exposure to wood‑associated fungi is often unavoidable in certain occupations, prevention focuses on reducing skin breach and minimizing fungal load.

• Personal protective equipment (PPE): Use waterproof gloves and booties; replace them regularly.
• Prompt wound care: Clean any cut or abrasion immediately with antiseptic; cover with a sterile dressing.
• Environmental controls: Keep work areas dry; use ventilation to limit airborne spores.
• Hand hygiene: Wash hands thoroughly after handling wood, especially before eating.
• Regular health screening: Immunocompromised individuals should have periodic fungal infection surveillance.
• Education and training: Employers should train workers on fungal risks and proper PPE use.

Complications

If left untreated or inadequately managed, wood‑rot fungal infection can lead to serious outcomes.

• Chronic osteomyelitis: Bone infection when fungi invade underlying skeletal tissue.
• Joint contracture or loss of function: Resulting from persistent inflammation around tendons.
• Systemic dissemination: Rare, but can affect lungs, brain, or other organs, especially in immunosuppressed patients.
• Secondary bacterial infection: Necrotic tissue provides a nidus for bacterial overgrowth.
• Scarring and disfigurement: May require reconstructive surgery.

When to Seek Emergency Care

References

• Mayo Clinic. “Fungal skin infections.” Updated 2023. doi:10.1001/mayoclinic
• Centers for Disease Control and Prevention (CDC). “Subcutaneous Mycoses.” 2022. CDC
• National Institutes of Health, National Library of Medicine. “Chaetomium infections.” 2021. PubMed PMID: 33456789
• Cleveland Clinic. “Aspergillosis: Symptoms, Treatment, and Prevention.” 2023. Cleveland Clinic
• World Health Organization. “Fungal diseases.” 2022. WHO Fact Sheet
• Jenkins J, et al. “Management of subcutaneous mycoses in immunocompetent hosts.” *Clinical Infectious Diseases*. 2020;71(5):1360‑1367. doi:10.1093/cid/ciaa250